Cellceutix Ushers in 2012 With Plans for Clinical Trials for Anti-Cancer and ... Healthcare world (press release) Regarding Cellceutix's drug for the attention of psoriasis , KM-133, the Company has optimized the drug and has completed writing the patent application. Cellceutix's intellectual geographical area law firm, Ladas & Parry, will now Be filing of patents for ... Link To Article
No comments:
Post a Comment